July 14, 2011
Vi-COR launches Celmanax's research results on livestock
Vi-COR, a manufacturer of specialised yeast culture products for poultry, swine and dairy feed, has announced research results that prove the ability of Celmanax to improve livestock gut health.
In-house experiments proved the ability of Celmanax Dry, Liquid and SCP to agglutinate forms of pathogenic E. coli and Salmonella sp.
One of the important metabolites in the product, Mannan Oligosaccharide (MOS), plays an important role in preventing infections by some pathogenic bacteria by agglutinating them (causing them to clump together) and preventing them from binding to the host tissue.
In other experiments, Celmanax bound mycotoxins and inhibited infection. "Experiments conducted by our microbiologist and independent laboratories prove that adding Celmanax to livestock feed can improve gut health and reduce likelihood of infections," says Mark Holt, Vi-COR president and CEO.
A great deal of emphasis is placed on genetics in today's livestock production. Holt explains that Vi-COR's products work hand-in-hand with this approach.
"Our technical development team formulates products to maximise those genetic capabilities," he says.
Research and development have been Holt's mantra since he purchased Vi-COR in 1999. He led the company through the rapid development of new products and technologies.
Vi-COR was the first company to develop a highly concentrated yeast culture, a liquid yeast culture and a soluble concentrated powder.
"For years, it was accepted that yeast-based products improve digestion and health of livestock, yet little was done to understand how they worked and why they were beneficial," says Holt. "Once we developed this understanding, it became apparent what we needed to make better products."